Cargando…
An update on the use of biologic therapies in the management of uveitis in Behçet’s disease: a comprehensive review
Behçet’s disease (BD) is a systemic vasculitis characterised by a relapsing remitting course, affecting multiple organ systems. In the eye, it is a cause of potentially blinding inflammation in the form of uveitis. Management of uveitis in BD often requires the use of systemic immunosuppression, in...
Autores principales: | McNally, Thomas W., Damato, Erika M., Murray, Philip I., Denniston, Alastair K., Barry, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513401/ https://www.ncbi.nlm.nih.gov/pubmed/28716038 http://dx.doi.org/10.1186/s13023-017-0681-6 |
Ejemplares similares
-
Pharmacotherapy for uveitis: current management and emerging therapy
por: Barry, Robert J, et al.
Publicado: (2014) -
Shaping the Future of Behçet’s Uveitis Management: A Comprehensive Review of Efficacy, Challenges, and Prospects of Biologic Therapies
por: Li, Biao, et al.
Publicado: (2023) -
mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis: a systematic review protocol
por: Blair, Joshua, et al.
Publicado: (2018) -
Behçet's Uveitis
por: Tugal-Tutkun, Ilknur
Publicado: (2009) -
Birmingham Behçet’s service: classification of disease and application of the 2014 International Criteria for Behçet’s Disease (ICBD) to a UK cohort
por: Blake, Tim, et al.
Publicado: (2017)